FOXO4-DRI vs Coenzyme Q10
Side-by-side comparison of FOXO4-DRI and Coenzyme Q10: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
FOXO4-DRI
Coenzyme Q10
FOXO4-DRI
FOXO4-DRI is a synthetic 46-amino-acid D-retro-inverso peptide designed to disrupt the interaction between the FOXO4 transcription factor and p53, with the specific goal of inducing apoptosis selectively in senescent…
Lowest listed price: $99.99 across 4 listings
Full FOXO4-DRI profileCoenzyme Q10
Coenzyme Q10 (CoQ10), also known as ubiquinone-10, ubidecarenone, or simply "coenzyme Q," is a lipid-soluble benzoquinone compound with a 50-carbon isoprenoid side chain (decaprenyl tail) that anchors it within the inner…
Lowest listed price: $74.99 across 1 listing
Full Coenzyme Q10 profileSide-by-side comparison
| Attribute | FOXO4-DRI | Coenzyme Q10 |
|---|---|---|
| Category | Recovery | Foundational |
| Research Stage | Preclinical | Dietary Supplement (Food Ingredient) |
| Mechanism of Action | FOXO4-DRI works by disrupting the protein-protein interaction between FOXO4 (Forkhead box O4) and p53 in senescent cells, which releases p53 from nuclear sequestration and allows it to translocate to the mitochondrial outer membrane where it triggers the… | Coenzyme Q10 operates through two mechanistically distinct functions — electron transport in oxidative phosphorylation and lipid-phase antioxidant defense — that together make it arguably the most important single molecule for cellular energy and membrane… |
| Half-Life | Not established in humans; no published human pharmacokinetic data. The D-retro-inverso construction confers resistance to human proteases, which in preclinical models extends the in vivo half-life from minutes (typical for comparable L-amino-acid peptides) to hours ([Baar et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28340339/)). | — |
| Typical Dose Range | No validated human dose. Self-report: 2-15 mg SC per dose (typically 5 mg), pulsed 3-7 days every 2-6 months; no human PK data. The 5 mg/kg figure seen in some sources is a mouse research dose (Baar 2017), not a human dose. | — |
| Dosing Frequency | — | — |
| Administration | — | — |
| Side Effects | The side effect profile of FOXO4-DRI in humans is not documented because no clinical trials have been conducted. Rodent studies from the Baar et al. 2017 publication and subsequent work report generally acceptable tolerability at doses producing senolytic… | Coenzyme Q10 has an exceptional safety profile across decades of clinical use, including the Q-SYMBIO trial population (NYHA III-IV heart failure, mean age 63) where no safety signals emerged over two years of high-dose therapy. Side effects are uncommon,… |
| Molecular Weight | 5358.2 g/mol (Methods, PMID: 28340339) | — |
| Common Vial Sizes | — | — |
Price History
4 data points- Half Nattys
- Ion Peptide
- Disguised Alpha
- LB
Price tracking
FOXO4-DRI: potential benefits
- Selective senescent cell clearance
- Potential reversal of aging markers
- Reduced chronic inflammation
- Improved tissue function
- Hair regrowth (animal studies)
- Organ rejuvenation potential
Coenzyme Q10: potential benefits
- No structured benefit list published.
Frequently asked
What's the difference between FOXO4-DRI and Coenzyme Q10?
FOXO4-DRI is a recovery that foxo4-dri works by disrupting the protein-protein interaction between foxo4 (forkhead box o4) and p53 in senescent cells, which releases p53 from nuclear sequestration and allows…. Coenzyme Q10 is a foundational that coenzyme q10 operates through two mechanistically distinct functions — electron transport in oxidative phosphorylation and lipid-phase antioxidant defense — that together make it…. The two differ in mechanism, half-life (Not established in humans; no published human pharmacokinetic data. The D-retro-inverso construction confers resistance to human proteases, which in preclinical models extends the in vivo half-life from minutes (typical for comparable L-amino-acid peptides) to hours ([Baar et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28340339/)). vs not reported), and typical dose range.
Which has the longer half-life, FOXO4-DRI or Coenzyme Q10?
FOXO4-DRI has a half-life of Not established in humans; no published human pharmacokinetic data. The D-retro-inverso construction confers resistance to human proteases, which in preclinical models extends the in vivo half-life from minutes (typical for comparable L-amino-acid peptides) to hours ([Baar et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28340339/)).. Coenzyme Q10 has a half-life of not reported. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, FOXO4-DRI or Coenzyme Q10?
Lowest listed price on BodyHackGuide: FOXO4-DRI from $99.99, Coenzyme Q10 from $74.99. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack FOXO4-DRI and Coenzyme Q10?
Stacking depends on mechanism overlap, safety profile, and goals. FOXO4-DRI and Coenzyme Q10 should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy FOXO4-DRI or Coenzyme Q10
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.